-
-
-
-
-
-
-
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
-
-
-
-
-
-
-
RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports First Quarter 2023 Financial Results & Company Update
-
-
-
-
-
-
-
CUMBERLAND PHARMACEUTICALS REPORTS 2021 FINANCIAL RESULTS & COMPANY UPDATE
-
-
-
-
-
-
-
Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update
-
-
-
-
-
-
-
Cumberland Pharmaceuticals (CPIX) Announces Strategic Review
-
1,156,028 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

